Omega-3 PUFA Market Size

Global Omega-3 PUFA Market size was valued at USD 2.43 billion in 2023 and is poised to grow from USD 2.62 billion in 2024 to USD 4.78 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

Omega-3 Fats are a crucial component of cell membranes all across the body, and they have an impact on how cell receptors in these membranes work. They serve as the precursor for the production of hormones that control inflammation, arterial wall contraction and relaxation, and blood clotting. Eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA), three members of the family of lipids known as omega-3 polyunsaturated fatty acids (PUFA), are essential for the growth and development of the body as well as having several health advantages. They are thought to be wholesome and necessary for cell development and brain health. Since the human body is unable to create PUFA on its own, it is crucial to rely on external supplements to give the body these vital fats. Clinical research has demonstrated the benefits of omega-3 PUFAs in treating and preventing a variety of disorders, including inflammation, cancer, rheumatoid arthritis, coronary heart disease, and neurodegenerative, neuropsychiatric, and cancerous conditions. Because omega-3 PUFA supplements are frequently prescribed by cardiologists and other doctors, they have become the most popular dietary supplements globally. Additionally, there is a growing need for omega-3 in nutritional supplements, infant formula, functional food & drinks, animal feed & pet food, and infant formula. The expansion of the market is anticipated to be driven by commercial manufacturing methods throughout the course of the projected period.

US Omega-3 PUFA Market is poised to grow at a sustainable CAGR for the next forecast year.